Sanofi acquired commercialisation rights for the radiopharmaceutical AlphaMedix from Orana Med in September 2024.

Cognivia Signal will try to predict which patients are at risk of dropping out to give sponsors the opportunity to intervene.

While MFN will see US drug prices reduced to match other countries, by them increasing elsewhere and using alternative models, it is unlikely that R&D will be heavily impacted. Image credit: ...

The vaccine was generally well tolerated among the paediatric population, with no unexpected safety signals reported. Credit: PeopleImages/Shutterstock.com. Bavarian ...

Johnson & Johnson’s pipeline IL-23 blocker, icotrokinra, has met its primary endpoint in a Phase IIb study in ulcerative colitis, meaning the drug’s efficacy and safety will now be explored in the ...